| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Amy R Borenstein, James A Mortimer, Ding Ding, Gerard D Schellenberg, Charles DeCarli, Qianhua Zhao, Cathleen Copenhaver, Qihao Guo, Shugang Chu, Douglas Galasko, David P Salmon, Qi Dai, Yougui Wu, Ronald Petersen, Zhen Hon. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P. American journal of Alzheimer's disease and other dementias. vol 25. issue 3. 2010-08-09. PMID:20142627. |
effects of apolipoprotein e-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in shanghai: scobhi-p. to determine apolipoprotein e (apoe)-epsilon4 and -epsilon2 frequencies and risk of mild cognitive impairment (mci) and dementia in shanghai, china. |
2010-08-09 |
2023-08-12 |
Not clear |
| Christina E Wierenga, Nikki H Stricker, Ashley McCauley, Alan Simmons, Amy J Jak, Yu-Ling Chang, Lisa Delano-Wood, Katherine J Bangen, David P Salmon, Mark W Bond. Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease. NeuroImage. vol 51. issue 3. 2010-08-05. PMID:20298792. |
recent language studies in aging and dementia provide two complementary lines of evidence that: (1) measures of semantic knowledge and word-finding ability show declines comparable to those of episodic memory, and greater impairment than executive function measures, during the prodromal period of alzheimer's disease and (2) cognitively intact older adult carriers of the apolipoprotein e (apoe) epsilon4 allele also demonstrate poorer object naming than their low-risk peers. |
2010-08-05 |
2023-08-12 |
Not clear |
| Yi-Fang Chuang, Kathleen M Hayden, Maria C Norton, Joann Tschanz, John C S Breitner, Kathleen A Welsh-Bohmer, Peter P Zand. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dementia and geriatric cognitive disorders. vol 29. issue 3. 2010-07-09. PMID:20375505. |
association between apoe epsilon4 allele and vascular dementia: the cache county study. |
2010-07-09 |
2023-08-12 |
Not clear |
| Yi-Fang Chuang, Kathleen M Hayden, Maria C Norton, Joann Tschanz, John C S Breitner, Kathleen A Welsh-Bohmer, Peter P Zand. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dementia and geriatric cognitive disorders. vol 29. issue 3. 2010-07-09. PMID:20375505. |
the apoe epsilon4 allele is an established risk factor for alzheimer's disease, but reports of its association with vascular dementia (vad) have been inconsistent. |
2010-07-09 |
2023-08-12 |
Not clear |
| Chien-Hsiun Chen, Toshiki Mizuno, Robert Elston, Monica M Kariuki, Kathleen Hall, Fred Unverzagt, Hugh Hendrie, Samuel Gatere, Paul Kioy, Nilesh B Patel, Robert P Friedland, Raj N Kalari. A comparative study to screen dementia and APOE genotypes in an ageing East African population. Neurobiology of aging. vol 31. issue 5. 2010-06-28. PMID:18703255. |
a comparative study to screen dementia and apoe genotypes in an ageing east african population. |
2010-06-28 |
2023-08-12 |
human |
| Natalie L Marchant, Sarah L King, Naji Tabet, Jennifer M Ruste. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 5. 2010-06-21. PMID:20072115. |
we sought to investigate the profile of young-adult apolipoprotein e (apoe) varepsilon4 carriers across cognitive domains given that possession of this gene variant increases risk of developing dementia in later life. |
2010-06-21 |
2023-08-12 |
human |
| Jonas K Olofsson, Steven Nordin, Stefan Wiens, Margareta Hedner, Lars-Göran Nilsson, Maria Larsso. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiology of aging. vol 31. issue 4. 2010-06-08. PMID:18619712. |
the apoe gene is expressed in olfactory brain structures and is believed to play a role in neuronal regenerative processes as well as in development of alzheimer's disease (ad), the most common form of dementia. |
2010-06-08 |
2023-08-12 |
human |
| Jonas K Olofsson, Steven Nordin, Stefan Wiens, Margareta Hedner, Lars-Göran Nilsson, Maria Larsso. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiology of aging. vol 31. issue 4. 2010-06-08. PMID:18619712. |
the present results suggest that the apoe gene plays a role in olfactory functioning that is independent of dementia conversion within 5 years. |
2010-06-08 |
2023-08-12 |
human |
| Ruth O'Hara, Avinoam Luzon, Jeffrey Hubbard, Jamie M Zeitze. Sleep apnea, apolipoprotein epsilon 4 allele, and TBI: mechanism for cognitive dysfunction and development of dementia. Journal of rehabilitation research and development. vol 46. issue 6. 2010-05-26. PMID:20104407. |
the apoe epsilon 4 allele is associated with cognitive decline and the development of dementia in the general population as well as in patients with tbi. |
2010-05-26 |
2023-08-12 |
Not clear |
| Ruth O'Hara, Avinoam Luzon, Jeffrey Hubbard, Jamie M Zeitze. Sleep apnea, apolipoprotein epsilon 4 allele, and TBI: mechanism for cognitive dysfunction and development of dementia. Journal of rehabilitation research and development. vol 46. issue 6. 2010-05-26. PMID:20104407. |
increased understanding of the relationships among sleep apnea, the apoe epsilon 4 allele, and cognition could improve our ability to ameliorate one significant source of cognitive impairment and risk for dementia associated with tbi. |
2010-05-26 |
2023-08-12 |
Not clear |
| Alessandra Bizzarro, V Guglielmi, R Lomastro, A Valenza, A Lauria, C Marra, M C Silveri, F D Tiziano, C Brahe, C Masull. BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 3. 2010-05-20. PMID:20058037. |
we analyzed apoe and buche polymorphisms in 167 ad and 59 fronto-temporal dementia (ftd) patients compared with 129 healthy controls (hc). |
2010-05-20 |
2023-08-12 |
Not clear |
| Kiyoshi Kanaya, Shine Abe, Minoru Sakai, Hiroko Fujii, Toshihiko Iwamot. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype. Geriatrics & gerontology international. vol 10. issue 1. 2010-05-20. PMID:20102379. |
we conducted a study of changes in cognitive functions by long-term monitoring of dementia of alzheimer type (dat) patients to investigate the relationship between the progression of dat symptoms and the presence of apolipoprotein (apoe)4. |
2010-05-20 |
2023-08-12 |
Not clear |
| M Zintl, M Petkov, G Schmitz, G Hajak, H-H Klüneman. [Frontotemporal dementia in association with a family history of dementia and ApoE polymorphism]. Der Nervenarzt. vol 81. issue 1. 2010-04-08. PMID:19629426. |
[frontotemporal dementia in association with a family history of dementia and apoe polymorphism]. |
2010-04-08 |
2023-08-12 |
Not clear |
| M Zintl, M Petkov, G Schmitz, G Hajak, H-H Klüneman. [Frontotemporal dementia in association with a family history of dementia and ApoE polymorphism]. Der Nervenarzt. vol 81. issue 1. 2010-04-08. PMID:19629426. |
to examine the association between apolipoprotein e (apoe) and a family history of dementia in 1st- and 2nd-degree relatives of patients with frontotemporal dementia (ftd) with a dementia onset by age 70. |
2010-04-08 |
2023-08-12 |
Not clear |
| Lee-Fay Low, Melvyn H W Yap, Henry Brodat. Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. Neuroscience and biobehavioral reviews. vol 34. issue 3. 2010-04-07. PMID:19720080. |
this paper aims to systematically review the influence of apolipoprotein e (apoe) on the effects of potentially modifiable mid and late life risk factors for dementia. |
2010-04-07 |
2023-08-12 |
Not clear |
| Lee-Fay Low, Melvyn H W Yap, Henry Brodat. Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. Neuroscience and biobehavioral reviews. vol 34. issue 3. 2010-04-07. PMID:19720080. |
results suggest the deleterious effect of current smoking is limited only to persons without apoe epsilon 4 (4 out of 4 studies), apoe epsilon 4 increases the risk of dementia associated with greater fat consumption, particularly saturated fats (3 out of 4 studies), and increases the protective effect against dementia associated with hrt use (3 out of 5 with one of the non-significant studies suggesting a trend). |
2010-04-07 |
2023-08-12 |
Not clear |
| Lee-Fay Low, Melvyn H W Yap, Henry Brodat. Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. Neuroscience and biobehavioral reviews. vol 34. issue 3. 2010-04-07. PMID:19720080. |
there was evidence that apoe does not modify the risk of dementia associated with measures of, and treatments for cvd, other dietary factors, and estradiol levels. |
2010-04-07 |
2023-08-12 |
Not clear |
| Lee-Fay Low, Melvyn H W Yap, Henry Brodat. Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. Neuroscience and biobehavioral reviews. vol 34. issue 3. 2010-04-07. PMID:19720080. |
there is insufficient evidence for the recommendation of apoe testing to assist with tailoring risk reduction recommendations for dementia. |
2010-04-07 |
2023-08-12 |
Not clear |
| H A D Keage, F E Matthews, A Yip, L Gao, C McCracken, I G McKeith, D C Rubinsztein, C Brayn. APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study. Age and ageing. vol 39. issue 1. 2010-04-02. PMID:19939808. |
apoe and ace polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the mrc cfa study. |
2010-04-02 |
2023-08-12 |
Not clear |
| H A D Keage, F E Matthews, A Yip, L Gao, C McCracken, I G McKeith, D C Rubinsztein, C Brayn. APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study. Age and ageing. vol 39. issue 1. 2010-04-02. PMID:19939808. |
dementia risk conferred by apolipoprotein-e (apoe) and angiotensin-1-converting enzyme (ace) polymorphisms have been reported for the mrc cognitive function and ageing study (cfas) at 6-year follow-up. |
2010-04-02 |
2023-08-12 |
Not clear |